People · Operator
Named in public records as an officer, director or promoter · active 2008–2018 · Biotechnology, Other Technology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Concentric Analgesics, Inc. | — | Biotechnology | Series C | $130.8M | $477.6M | 2017 |
| Boka Sciences, Inc. | — | Other Technology | Seed | $2.1M | $35.8M | 2008 |
Frank Bellizzi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Frank Bellizzi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Frank Foster | 1 | 12 |
| John Donovan | 1 | 8 |
| Thomas King | 1 | 6 |
| Stephen Watkins | 1 | 4 |
| Branden Rosenhan | 1 | 3 |
| Thomas F. King | 1 | 1 |
| Larry F. Feinberg | 1 | 1 |
| Craig Husfeld | 1 | 1 |
| Porter Jones | 1 | 1 |
| Grant Donovan | 1 | 1 |
| Andrew Byars | 1 | 1 |
| Frank J. Bellizzi | 1 | 1 |
| Craig F. Husfeld | 1 | 1 |
| John F. Donovan | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.